Tag Archives: bmy

Bristol-Myers Hits 14-Year High On Big Cancer News

Big pharma Bristol-Myers Squibb (BMY) said Wednesday that it inked a deal worth up to $975 million with Danish biotech Bavarian Nordic for its prostate-cancer vaccine candidate Prostvac, a step forward for a technology that still has yet to prove itself. Bristol agreed to pay $60 million upfront, with the rest of the money dependent on how Prostvac gets through its phase-three trial and the FDA approval process. Bristol said it’s also planning a

Bristol-Myers Lung Cancer Drug Opdivo Wins Speedy OK

The Food and Drug Administration approved Bristol-Myers Squibb’s (BMY) PD-1 inhibitor Opdivo for squamous-cell lung cancer Wednesday, well ahead of the expected timeline. The stock jumped to a 14-year high near 65. Opdivo was first approved for advanced melanoma in December, and positive lung-cancer data in January increased Wall Street’s confidence that it would also get approved for that disease. However, they weren’t all prepared for it to

Bristol-Myers Backs Bavarian Nordic Cancer Vaccine

Big pharma Bristol-Myers Squibb (BMY) said Wednesday that it inked a deal worth up to $975 million with Danish biotech Bavarian Nordic for its prostate-cancer vaccine candidate Prostvac, a step forward for a technology that still has yet to prove itself. Bristol agreed to pay $60 million upfront, with the rest of the money dependent on how Prostvac gets through its phase-three trial and the FDA approval process. Bristol said it’s also planning a